These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 8774549
1. Immunity in the connective tissue diseases. The humoral side of the coin. Williams RC, Malone CC. Scand J Rheumatol; 1996; 25(1):5-15. PubMed ID: 8774549 [Abstract] [Full Text] [Related]
2. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. Williams RC, Staud R, Malone CC, Payabyab J, Byres L, Underwood D. J Immunol; 1994 May 01; 152(9):4722-37. PubMed ID: 8157982 [Abstract] [Full Text] [Related]
3. Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. Chang L, Binos S, Savige J. Clin Exp Immunol; 1995 Oct 01; 102(1):112-9. PubMed ID: 7554377 [Abstract] [Full Text] [Related]
4. Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies. Witko-Sarsat V, Halbwachs-Mecarelli L, Almeida RP, Nusbaum P, Melchior M, Jamaleddine G, Lesavre P, Descamps-Latscha B, Gabay JE. FEBS Lett; 1996 Mar 11; 382(1-2):130-6. PubMed ID: 8612734 [Abstract] [Full Text] [Related]
5. Anti-cytoplasmic antibodies in Wegener's granulomatosis are directed against proteinase 3. Lüdemann J, Utecht B, Gross WL. Adv Exp Med Biol; 1991 Mar 11; 297():141-50. PubMed ID: 1722626 [No Abstract] [Full Text] [Related]
6. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Van Der Geld YM, Simpelaar A, Van Der Zee R, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG. Kidney Int; 2001 Jan 11; 59(1):147-59. PubMed ID: 11135067 [Abstract] [Full Text] [Related]
7. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis. Gross WL, Csernok E, Flesch BK. J Autoimmun; 1993 Apr 11; 6(2):171-84. PubMed ID: 8388690 [Abstract] [Full Text] [Related]
8. Rheumatoid factors from patients with rheumatoid arthritis react with beta 2-microglobulin. Williams RC, Malone CC, Tsuchiya N. J Immunol; 1992 Aug 01; 149(3):1104-13. PubMed ID: 1378864 [Abstract] [Full Text] [Related]
9. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies. Van Der Geld YM, Limburg PC, Kallenberg CG. Clin Exp Immunol; 1999 Dec 01; 118(3):487-96. PubMed ID: 10594572 [Abstract] [Full Text] [Related]
10. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. Bini P, Gabay JE, Teitel A, Melchior M, Zhou JL, Elkon KB. J Immunol; 1992 Aug 15; 149(4):1409-15. PubMed ID: 1380042 [Abstract] [Full Text] [Related]
11. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis. Gaskin G, Kendal H, Coulthart A, Turner N, Pusey CD. J Immunol Methods; 1995 Mar 13; 180(1):25-33. PubMed ID: 7897245 [Abstract] [Full Text] [Related]
12. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells. Van der Geld YM, Smook ML, Huitema MG, Harmsen MC, Limburg PC, Kallenberg CG. J Immunol Methods; 2002 Jun 01; 264(1-2):195-205. PubMed ID: 12191522 [Abstract] [Full Text] [Related]
13. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, Specks U. J Immunol Methods; 1998 Feb 01; 211(1-2):111-23. PubMed ID: 9617836 [Abstract] [Full Text] [Related]
14. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Ann Intern Med; 1997 Jun 01; 126(11):866-73. PubMed ID: 9163287 [Abstract] [Full Text] [Related]
15. Anti-proteinase 3 antibodies, their characterization and disease associations. Jennings JG, Chang L, Savige JA. Clin Exp Immunol; 1994 Feb 01; 95(2):251-6. PubMed ID: 8306500 [Abstract] [Full Text] [Related]
16. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins. Selga D, Segelmark M, Wieslander J, Gunnarsson L, Hellmark T. Clin Exp Immunol; 2004 Jan 01; 135(1):164-72. PubMed ID: 14678279 [Abstract] [Full Text] [Related]
17. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. Baslund B, Petersen J, Permin H, Wiik A, Wieslander J. J Immunol Methods; 1994 Oct 14; 175(2):215-25. PubMed ID: 7930650 [Abstract] [Full Text] [Related]
18. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. Abdel-Salam B, Iking-Konert C, Schneider M, Andrassy K, Hänsch GM. Kidney Int; 2004 Sep 14; 66(3):1009-17. PubMed ID: 15327394 [Abstract] [Full Text] [Related]
19. Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis. Peen E, Malone C, Myers C, Williams RC, Peck AB, Csernok E, Gross WL, Staud R. Clin Exp Immunol; 2001 Aug 14; 125(2):323-31. PubMed ID: 11529926 [Abstract] [Full Text] [Related]
20. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis. Gaskin G, Turner AN, Ryan JJ, Rees AJ, Pusey CD. Adv Exp Med Biol; 1993 Aug 14; 336():287-9. PubMed ID: 8296619 [Abstract] [Full Text] [Related] Page: [Next] [New Search]